Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of cancer cachexia.

Michael J Tisdale1

  • 1Pharmaceutical Sciences Research Institute, Aston University, Aston Triangle, Birmingham, United Kingdom. m.j.tisdale@aston.ac.uk

The Journal of Supportive Oncology
|September 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression.

Scientific reports·2020
Same author

Ken Fearon.

Cell metabolism·2016
Same author

In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.

In vitro cellular & developmental biology. Animal·2016
Same author

Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.

Nutrition (Burbank, Los Angeles County, Calif.)·2014
Same author

Attenuation of muscle wasting in murine C2C 12 myotubes by epigallocatechin-3-gallate.

Journal of cachexia, sarcopenia and muscle·2014
Same author

Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG).

Endocrinology·2012

Cachexia, a cancer-related wasting syndrome, involves muscle and fat loss driven by factors beyond simple energy deficit. Eicosapentaenoic acid shows promise in stabilizing body weight by reducing muscle protein degradation.

Area of Science:

  • Oncology
  • Biochemistry
  • Metabolism

Background:

  • Cachexia affects approximately 50% of cancer patients, characterized by significant adipose tissue and skeletal muscle loss.
  • While anorexia is common, the energy deficit alone does not fully explain cachexia's pathogenesis.
  • The acute phase response (APR), involving cytokines like IL-6 and IL-8, is linked to accelerated weight loss and reduced survival in cancer patients.

Purpose of the Study:

  • To elucidate the complex mechanisms underlying cancer cachexia.
  • To identify key molecular factors contributing to adipose tissue and skeletal muscle wasting.
  • To explore potential therapeutic interventions for cachexia.

Main Methods:

  • Investigated the role of cytokines (IL-6, IL-8) and tumor factors (PIF) in initiating the APR.

Related Experiment Videos

  • Examined the expression of uncoupling protein-3 in muscle and its impact on energy expenditure.
  • Analyzed triglyceride metabolism in adipose tissue and protein degradation pathways in skeletal muscle.
  • Assessed the effects of eicosapentaenoic acid on protein degradation and body weight stabilization.

    • Main Results:

    • Proteolysis inducing factor (PIF) and tumor necrosis factor-alpha induce the ATP-ubiquitin-dependent proteolytic pathway in muscle.
    • Tumor lipid mobilizing factor may increase lipolysis via a cyclic AMP-mediated process and beta3-adrenergic receptor.
    • Eicosapentaenoic acid effectively reduces muscle protein degradation by inhibiting proteasome expression.

    Conclusions:

    • Cancer cachexia involves complex molecular pathways affecting both fat and muscle tissue.
    • Therapeutic strategies targeting protein degradation pathways, such as using eicosapentaenoic acid, may help manage cachexia and stabilize body weight in cancer patients.